Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3932-3957
Author(s):
Ana R. Quesada, Miguel Angel Medina, Ramon Munoz-Chapuli and Angel Luis G. Ponce
Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3877-3894
Author(s):
Magdalena Tertil, Alicja Jozkowicz and Jozef Dulak
Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3864-3876
Author(s):
Carine Munaut, Alain C. Colige and Charles A. Lambert
Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
13
Page:
849-854
Author(s):
Serkan Sertel, Peter K. Plinkert and Thomas Efferth
Heme Oxygenase-1 in Tumor Biology and Therapy
Journal:
Current Drug Targets
Volume:
11
Page:
1551-1570
Author(s):
Halina Was, Jozef Dulak and Alicja Jozkowicz
Targeting the Resistance of Pancreatic Cancer Cells to Nutrient Deprivation: Anti-Austerity Compounds
Journal:
Current Drug Delivery
Volume:
7
Page:
355-369
Author(s):
Jakob Magolan and Mark J. Coster
Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
840-848
Author(s):
H.-W. Lo
Anti-Angiogenic Therapies for Children with Cancer
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
879-889
Author(s):
N. Andre, A. Verschuur, J. Rossler and J. Sterba
Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
898-913
Author(s):
D. Mottet and V. Castronovo
Novel Agents in the Management of Lung Cancer
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4291-4325
Author(s):
B. Kennedy, F. Gargoum, B. Bystricky, D. R. Curran and T. M. O'Connor